Canopy Growth (TSX:WEED): 1 of the Best Marijuana Stocks to Buy

The marijuana space is becoming big and confusing. There are several companies in Canada and the U.S. trying to win investor confidence in this nascent industry by putting out ambitious growth plans.  But if you’re a long-term investor and are thinking of getting some exposure to this new growth area, then I highly recommend sticking with the big players, which…

Read More

CBD Life Sciences, Inc. (OTC Pink: CBDL) Surges 71% After Negotiations to Enter Japanese Market

CBD Life Sciences, Inc. (OTC Pink: CBDL), through its subsidiary, LBC Bioscience, Inc., is actively engaged in the emerging hemp CBD market. Specifically, LBC Bioscience is focused on developing and marketing a line of organic, cannabinoid-based products: hemp drops, massage oil, pain relief creams, supplements, edibles, pet products, anxiety/sleep products, and more. Shares of the CBD company are surging 71%,…

Read More

Canopy Growth (TSX:WEED) Is Joining the S&P/TSX 60 Index: Time to Buy?

It’s shaping up to be another big year for Canopy Growth (TSX:WEED)(NYSE:CGC). After getting off to a great start in early 2019, the company continued its expansion, acquiring Spanish producer Cafina and pursuing a licence to sell pot in New York State. As a result of its rapid growth, Canopy is set to become the first weed stock on the S&P/TSX…

Read More

Aphria Inc. (TSX:APHA) Disappoints: Is the Stock Price Attractive Today?

I have long written about the problem with cannabis stocks and their valuations and the expectations that are built into them. I’ve also written about the strong likelihood that higher-than-expected spending, shareholder dilution, and slower-than-expected revenue growth will likely be very detrimental to stock prices. The industry, cycle, and growth are in their early stages. Aphria (TSX:APHA)(NYSE:APHA) reported its third-quarter…

Read More

MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) Gains 10% After Receiving DTC Eligibility

MediPharm Labs Corp.

MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) is a global leader in the cannabis extraction space. The company focuses on specialized and research-driven extraction, distillation, purification, and isolation. The cannabis extraction company’s Canadian-listed shares are gaining 10%, through afternoon trading on Tuesday, April 16, 2019. Over the past three months, MediPharm Labs has seen average daily volume of 858,047 shares.…

Read More

3 Takeaways From Aphria Inc’s (TSX:APHA) Q3 Results

Aphria (TSX:APHA)(NYSE:APHA) released its third-quarter results on Monday. The company’s revenues were up more than 600% in what was its first quarter with a full three months of recreational sales. However, with Aphria recording a loss of more than $108 million, investors were left unimpressed, as the stock dropped 14% on the day the results were announced. It was a…

Read More

Vapor Group, Inc. (OTC Pink: VPOR) Rallies 25% After Securing $100,000 Purchase Order From White Label Liquid, Inc. (OTC Pink: WLAB)

Vapor Group, Inc.

Vapor Group, Inc. (OTC Pink: VPOR) operates as a holding company that primarily operates a principal subsidiary called VPOR, Inc. The company’s focus is to source, distribute, and sale premium bulk hemp CBD products. Vapor Group sources its hemp from top producers in states like Kentucky, Colorado, and Oregon. Vapor Group also owns Simple Cork, Inc., a patented wine bottle…

Read More

Could Canopy Growth Corp (TSX:WEED) Fall Below $50?

The hype for marijuana stocks has been strong in recent years. However, not everyone is sold on their ability to meet the expectations that Wall Street has set for them. With a lot of hurdles present in the cannabis industry and many hiccups since legalization, it hasn’t been smooth sailing. Canopy Growth Corp  (TSX:WEED)(NYSE:CGC) has been no exception to that…

Read More